Bypassing multidrug resistance in cancer cells with biodegradable polymer capsules.
Yan
Yan
Y
Centre for Nanoscience and Nanotechnology, Department of Chemical and Biomolecular Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia.
Ochs
Christopher J
CJ
Such
Georgina K
GK
Heath
Joan K
JK
Nice
Edouard C
EC
Caruso
Frank
F
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D001672:Biocompatible Materials / Q000737:chemistry*; D002214:Capsules / Q000737:chemistry*; D045744:Cell Line, Tumor; D004317:Doxorubicin / Q000627:therapeutic use / Q000633:toxicity; D019008:Drug Resistance, Neoplasm; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D017239:Paclitaxel / Q000627:therapeutic use / Q000633:toxicity; D011108:Polymers / Q000737:chemistry*; D011109:Polymethacrylic Acids / Q000737:chemistry; D011145:Polyvinyls / Q000737:chemistry; D011759:Pyrrolidines / Q000737:chemistry
D000903:Antibiotics, Antineoplastic; D001672:Biocompatible Materials; D002214:Capsules; D011108:Polymers; D011109:Polymethacrylic Acids; D011145:Polyvinyls; D011759:Pyrrolidines; C505150:poly(N-vinylpyrrolidine); C030613:polymethacrylic acid; D004317:Doxorubicin; D017239:Paclitaxel